Apotex Corp. recalls Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, C…
- Recall date
- April 8, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0510-2026
- FDA classification
- Class II
- Brand / firm
- Apotex Corp.
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Get recall alerts
Free email alert whenever Apotex Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Apotex Corp.